Neumora Therapeutics, Inc. (NMRA) stock
NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.43−0.00 (-0.95%)
Close on Nov 13, 2026Market cap $80.59MP/E –Yield –
Neumora Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Neumora Therapeutics's enterprise value was $78.31M on Nov 11, 2026, against $229.79M a year earlier. Over the last 3 years it ranged from -$181.48M to $2.35B, with a median of $114.75M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $78.31M | -50.2% |
| 2025 | Dec 31, 2025 | $157.11M | -84.1% |
| 2024 | Apr 30, 2024 | $989.80M | +1463.5% |
| 2023 | Dec 29, 2023 | $63.31M | – |
See a number that looks wrong?